09939 开拓药业－Ｂ
按盘价 
0.960 0.000 (0.000%) | 2023/12 - 末期 人民币() | 2022/12 人民币() | 2021/12 人民币() | 2020/12 人民币() | 2019/12 人民币() | |
| 经营活动之现金流量 | (387,581,000) | (961,260,000) | (1,051,363,000) | (380,882,000) | (228,042,000) |
| 投资活动之现金流量 | 3,274,000 | 67,195,000 | 92,005,000 | (439,728,000) | (7,013,000) |
| 融资活动之现金流量 | (33,463,000) | 815,750,000 | 857,418,000 | 1,780,298,000 | 295,852,000 |
| 现金及等同现金之增加/(减少) | (417,770,000) | (78,315,000) | (101,940,000) | 959,688,000 | 60,797,000 |
| 期初之现金及现金等价物 | 864,470,000 | 926,331,000 | 1,064,689,000 | 195,532,000 | 137,513,000 |
| 汇率变动之影响 | (2,673,000) | 16,454,000 | (36,418,000) | (90,531,000) | (2,778,000) |
| 其他 | 0 | 0 | 0 | 0 | 0 |
| 期末之现金及现金等价物 | 444,027,000 | 864,470,000 | 926,331,000 | 1,064,689,000 | 195,532,000 |
| 备注： | 实时报价更新时间为29/04/2024 17:59 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) () | RMB -1,060,820,000 |
| 增长率 | 11.154% |
| 每股盈利/(亏损) | RMB -2.470 |
| 每股账面资产净值 (¥) | RMB 1.024 |